Insilico Medicine is a clinical-stage biotechnology company applying generative AI and robotic automation to drug discovery and development. Its Pharma.AI software suite includes PandaOmics (target discovery from multi-omics data), Chemistry42 (generative chemistry with retrosynthesis, property prediction, and ADMET), Generative Biologics…
drug-discovery clinical-trials aging longevity biotech multi-omics pharmaceuticals target-discovery admet apis-json retrosynthesis generative-ai generative-chemistry pharma-ai chemistry42 pandaomics
-
Updated
Aug 12, 2026